Concepedia

Duncan Shaw

DS

Statistics

Publications

31

Citations

1.2K

H-Index

23

Active since

1964

Affiliations

MSD (UK) Limited (United Kingdom)(Current)

Queen Mary University of London

Merck & Co., Inc., Rahway, NJ, USA (United States)

University of Nottingham

Novartis (Switzerland)

Duncan Shaw is an author at MSD (UK) Limited (United Kingdom) specializing in natural sciences, chemistry, and medicinal chemistry.

ORCID

Publications per year

1964–2025

31

Publications

31

Effect of the CGRP receptor antagonist BIBN4096BS in human cerebral, coronary and omental arteries and in SK-N-MC cells

Lars Edvinsson, Rikard Alm, Duncan Shaw et al. · European Journal of Pharmacology · 2002 · 116 citations

, , +11

Aryl sulfones: a new class of γ-secretase inhibitors

Martin Teall, Paul Oakley, Timothy Harrison et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 113 citations · Full text

, , +7

Synthesis of quinol-4-ones and chroman-4-ones via a palladium-catalysed cascade carbonylation–allene insertion

Ronald Grigg, Angela Liu, Duncan Shaw et al. · Tetrahedron Letters · 2000 · 95 citations

, , +7

4-Substituted cyclohexyl sulfones as potent, orally active γ-secretase inhibitors

Ian Churcher, Dirk Beher, Jonathan D. Best et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 80 citations · Full text

, , +9

2-Aryl Indole NK1 receptor antagonists: optimisation of indole substitution

Laura C. Cooper, Gary G. Chicchi, Kevin Dinnell et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 70 citations · Full text

, , +11

1–5 of 31